The GLP is committed to full transparency. Download and review our 2019 Annual Report

Can genome editing cure AIDS?

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Yes. At least, in theory. But, theory might soon become practice according to the prestigious New England Journal of Medicine. It published the first clinical trial of genome editing, in which the DNA of 12 human

volunteers was “edited” to make them “genetically resistant” to the HIV virus.
What do I mean by genome editing and is it safe? How is this different from other gene therapies? Why would this cure AIDS? Is it unethical to genetically modify humans? And of course most importantly, should we be worried about “genetically modified super-humans” taking over the planet?

Read the full, original story: CAN GENOME EDITING CURE AIDS?

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend